Giovanni Manfredi Assanto | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al	JOURNAL OF THROMBOSIS AND HAEMOSTASIS	2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study	HEMATOLOGICAL ONCOLOGY	2022
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study	BLOOD	2022
Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience	BONE MARROW TRANSPLANTATION	2021
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic	JAC-ANTIMICROBIAL RESISTANCE	2021
High basal maximal standardized uptake value (Suvmax) in follicular lymphoma identifies patients with a low risk of long-term relapse	CANCERS	2021
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience (Bone Marrow Transplantation, (2021), 56, 6, (1455-1457), 10.1038/s41409-020-01174-w)	BONE MARROW TRANSPLANTATION	2021
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects	BRITISH JOURNAL OF HAEMATOLOGY	2021
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2020
Hematopoietic Stem Cell Transplantation in Myelofibrosis: The Experience of Three University Transplant Centres in Rome	BONE MARROW TRANSPLANTATION	2020
Incidence and outcome of severe complications in patients with paroxysmal nocturnal hemoglobinuria: A real life scenario from a single center 30 years experience	BONE MARROW TRANSPLANTATION	2019